The Barriers and Facilitators of Different Stakeholders When Deprescribing Benzodiazepine Receptor Agonists in Older Patients—A Systematic Review
Treatment of older patients with benzodiazepines and Z-drugs (BZRA) is associated with an increased risk of side effects. However, this treatment is still used among these patients. Deprescribing can be a tool to reduce inappropriate medication. This review aims to identify and compare barriers and...
Main Authors: | Anja Fog Rasmussen, Sarah Sonne Poulsen, Lykke Ida Kaas Oldenburg, Charlotte Vermehren |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-04-01
|
Series: | Metabolites |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-1989/11/4/254 |
Similar Items
-
Tapering (deprescribing) of benzodiazepine tranquilizers
by: D. A. Sychev, et al.
Published: (2019-03-01) -
The role of pharmacists in deprescribing benzodiazepines: A scoping review
by: Fatemah Zakariya Ashkanani, et al.
Published: (2023-12-01) -
Current practice in benzodiazepine receptor agonists deprescribing on acute geriatric wards: a cohort study
by: François-Xavier Sibille, et al.
Published: (2022-02-01) -
Barriers and enablers towards benzodiazepine-receptor agonists deprescribing in nursing homes: A qualitative study of stakeholder groups
by: Perrine Evrard, et al.
Published: (2023-03-01) -
Deprescribing Strategies for Opioids and Benzodiazepines with Emphasis on Concurrent Use: A Scoping Review
by: Yanning Wang, et al.
Published: (2023-02-01)